(2E,4E)-N-benzyl-5-(6-chloropyridin-2-yl)-2-cyanopenta-2,4-dienamide | 1204306-39-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: (2E,4E)-N-benzyl-5-(6-chloropyridin-2-yl)-2-cyanopenta-2,4-dienamide
• CAS: 1204306-39-7
• 化学式: C₁₈H₁₄ClN₃O
• 分子量: 323.782
• InChiKey: KPNOFHCLSYYXOF-NRCQFBCTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  65.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Novel Inhibitors of Proliferation and Activation of Signal Transducer and Activator of Transcription (STATS)
  申请人：Priebe Waldemar

  公开号：US20110053992A1

  公开（公告）日：2011-03-03

  Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders.

  提供有效调节STAT3和/或STAT5激活的吡啶化合物，可用于预防和治疗增生性疾病和病症，包括癌症、炎症和增生性皮肤疾病。
• NOVEL INHIBITORS OF PROLIFERATION AND ACTIVATION OF SIGNAL TRANSDUCER AND ACTIVATORS OF TRANSCRIPTION (STATS)
  申请人：Priebe Waldemar

  公开号：US20120149738A1

  公开（公告）日：2012-06-14

  Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders.

  提供了能够有效调节STAT3和/或STAT5激活的吡啶化合物，可用于预防和治疗增生性疾病和病症，包括癌症、炎症和增生性皮肤疾病。
• NOVEL INHIBITORS OF PROLIFERATION AND ACTIVATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STATS)
  申请人：Board of Regents, The University of Texas System

  公开号：US20140228414A1

  公开（公告）日：2014-08-14

  Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders.

  提供了在调节STAT3和/或STAT5激活方面有效的吡啶化合物，这些化合物在预防和治疗增生性疾病和病症中包括癌症、炎症和增生性皮肤疾病方面具有用处。
• INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION
  申请人：Board of Regents, The University of Texas System

  公开号：EP2506852A2

  公开（公告）日：2012-10-10
• METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS
  申请人：Priebe Anna

  公开号：US20110275577A1

  公开（公告）日：2011-11-10

  The present invention relates to caffeic acid analog compounds and methods which may be useful for regeneration, cellular programming, and the treatment of dermatologic, gynecologic, and genital diseases such as inflammatory dermatologic conditions, dysplasia, neoplasia, in situ carcinoma, invasive carcinoma, lichen sclerosus, lichen planus, vaginal dysplasia, vaginal carcinoma, vulvar dysplasia, vulvar carcinoma, cervical dysplasia, cervical carcinoma, and Kaposi's sarcoma.